Publications by authors named "Molly Barkhouse"
Article Synopsis
- Duchenne muscular dystrophy (DMD) is caused by a lack of dystrophin, leading to harmful cellular processes that contribute to disability; current treatments mainly focus on replacing dystrophin but may not fully address downstream effects.
- A study used mdx mice to test various drugs, including prednisolone and vamorolone, and found significant overlap in biomarkers between these drugs, indicating similar impacts on key pathways related to DMD.
- The research highlights the potential for biomarker analysis to help assess and optimize drug combinations for treating DMD in both animal models and humans.
